In addition, after chemotherapy, cancer cell-derived EVs induce CD8+ T-cell apoptosis and alter cytokine-related gene expression, leading to an immunosuppressive TME that hinders effective anti-tumor immunity (43). The gene discussed is CD8A; the disease is cancer.